We offer comprehensive solutions for all phases of implant therapy, including ANKYLOS®, ASTRA TECH Implant System™ and XiVE® implant lines, digital technologies, such as ATLANTIS™ patient-specific CAD/CAM solutions and SIMPLANT® guided surgery, SYMBIOS® regenerative solutions, and professional development programs. DENTSPLY Implants creates value for dental professionals and allows for predictable and lasting implant treatment outcomes, resulting in enhanced quality of life for patients. All products may not be regulatory cleared/released/licensed in all markets.
Type
Public
HQ
Weybridge, GB
Founded
2001
Size (employees)
15,700 (est)
DENTSPLY International was founded in 2001 and is headquartered in Weybridge, GB
Report incorrect company information

DENTSPLY International Office Locations

DENTSPLY International has an office in Weybridge
Weybridge, GB (HQ)
The Heights
Show all (1)
Report incorrect company information

DENTSPLY International Financials and Metrics

DENTSPLY International Financials

DENTSPLY International's revenue was reported to be £177.05 m in FY, 2016
GBP

Revenue (FY, 2016)

177.1 m

Gross profit (FY, 2016)

47.5 m

Gross profit margin (FY, 2016), %

26.8%

Net income (FY, 2016)

(52 k)

EBITDA (FY, 2016)

949 k

EBIT (FY, 2016)

419 k

Market capitalization (27-Oct-2017)

14.1 b

Closing share price (27-Oct-2017)

61.4

Cash (31-Dec-2016)

10.8 m
DENTSPLY International's current market capitalization is $14.1 b.
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

31.1 m33.6 m35.8 m37.2 m39.2 m41.5 m50.5 m53.2 m74.3 m177.1 m

Revenue growth, %

9%(6%)5%2%

Cost of goods sold

21.3 m24 m24.9 m26.1 m26.9 m28 m34.3 m37.4 m55.7 m129.6 m

Gross profit

9.8 m9.6 m10.8 m11 m12.3 m13.6 m16.2 m15.8 m18.5 m47.5 m
GBPFY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

2.7 m2.1 m2.3 m2.2 m3.1 m3.6 m3.9 m4.3 m3.8 m(52 k)

Dividends Paid

20 m

Income Taxes Paid

(1.3 m)(1.2 m)(750 k)
GBPY, 2016

Revenue/Employee

15.5 k

Financial Leverage

4.8 x
Show all financial metrics
Report incorrect company information